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Strategies for improvement of nerve regeneration and optimal conditions to prevent Schwann cell (SC) loss within a nerve
transplantprocedurearecritical.ThepurposeofthisstudywastoexamineSCviability,whichplaysanimportantroleinperipheral
nerve regeneration, under various incubation conditions up to three hours. To address this issue, Schwann cell metabolic activity
was determined using diﬀerent independent test methods. The following experimental conditions were compared: SCs prepared
from nerves were incubated in (1) isotonic saline solution (2) Dulbecco’s modiﬁed Eagles medium as used for cell culturing,
(3) Hannover bioreactor medium, and (4) Leibovitz’s medium. SC metabolic activity of excised rat sciatic nerve was determined
at 4◦C, 18◦C, and 37◦C over 3hrs. The results indicate that SC activity was optimized by the usage of Leibovitz’s medium or
HBRM at 37◦C. Greater SC viability at the time of surgical nerve grafting could contribute to improved axonal regeneration and
remyelination after nerve transplantation, and thus more successful functional recovery.
1.Introduction
Axonal regeneration and remyelination after peripheral
nerve injury can be robust with signiﬁcant functional re-
covery in contrast to the central nervous system where long
white matter tract regeneration is absent or minimal [1].
After peripheral nerve transection, for example, after tumor
resection, Wallerian degeneration characterized by macro-
phage inﬁltration, axonal membrane digestion, and retrac-
tion and proliferation of SCs occurs in the distal nerve
segment [2]. The detached SCs from the degenerating axons
upregulate the expression of nerve growth factor (NGF) and
its low-aﬃnity receptor p75NGFR [3]. For a period of time
these SCs are activated [4] and provide trophic support for
regeneration. Regeneration occurs from the proximal stump
by axonal sprouting and elongation and continues into the
distal stump or nerve transplant [5]. The status of a nerve
transplant is critical for successful nerve regeneration.
While nerve regeneration through Schwann-cell-en-
riched basal lamina tubes can reestablish connections with
p e r i p h e r a lt a r g e t ss u c ha ss k i na n dm u s c l e ,an u m b e ro f
issues, such as navigation of axons across a complex nerve
injury site where scarring can occur and appropriate target-
ing to peripheral end structures are major clinical concerns
[6]. Although local endogenous SCs play an important
role in regeneration of peripheral nerve, transplantation of
additional Schwann cells into a lesion site was shown to
assist this regenerative process [7, 8]. Nerve repair combined
with transplantation of myelin-forming cell is a relatively
simple, rapid, and eﬃcient means of peripheral nerve repair
[9]. Moreover, functional nerve regeneration requires not
onlyaxonalsproutingandelongation,butalsoremyelination
and appropriate ion channel deployment at the node of
Ranvier [8, 9]. The combination of surgical nerve repair
and transplantation of peripheral myelin-forming cells has
been shown to enhance axonal regeneration and remyelinate
demyelinated ﬁbers in experimental models [10] and is cur-
rently being investigated in clinical studies [7, 11].
In nerve defect injuries treated with autologous nerve
transplantation, the nerve ﬁbers within the transplant con-
tain a high number of Schwann cells which are indirectly
transplanted; the viability and activity of these indirectly
engrafted Schwann cells may be critical to optimize success2 International Journal of Otolaryngology
of the nerve graft. The importance of the Schwann cells and
their basal lamina for axonal regeneration is well established
[4, 10, 12]. Loss of viable Schwann cells in a nerve graft
results in a reduced neurotrophic support with an attendant
reduction in regeneration [13, 14]. Thus, the holding
conditions for nerve segments removed for nerve grafting
are critical for both SC preservation and potential success of
the graft. In the present study, we compared various holding
conditions including temperature and medium for short-
term preservation (up to 3 hours) followed by determination
of Schwann cell viability assessed by two independent test
methods after dissociation of excised nerve segments as used
for nerve transplantation.
2.MaterialsandMethods
2.1. Isolation and Cultivation of Schwann Cells. Experiments
were performed in accordance with the German Animal
welfare guidelines for the care and use of laboratory ani-
mals. The Hannover Medical School and the Nds. Lan-
desamt f¨ ur Verbraucherschutz und Lebensmittelsicherheit
approved all animal protocols. For preparation of adult
Schwann cells, adult male Sprague-Dawley rats were deeply
anesthetized and sciatic nerves were removed. The sciatic
nerves were desheathed, minced, and washed with 10mL
serum-free DMEM low glucose (1g/L) with L-Glutamine
(PAA, Pasching Austria), transferred to a 15mL tube (TPP,
Europe, Switzerland) and washed by centrifugation. For
enzymatic dissociation, 15mg lyophilized Collagenases A
and D (Roche, Mannheim, Germany) were dissolved in
10mL serum-free DMEM; the nerve tissue was incubated
at 37◦C and 5% CO2 for 20min followed by trituration
through a ﬁre-polished siliconized pasteur pipette and
washed for three times with DMEM containing 10% FCS.
The cells were resuspended and either seeded onto two
25cm2 cell culture ﬂasks (TPP, Europe, Switzerland) coated
with Laminin (Engelbreth-Holm-Swarm murine sarcoma
basement membrane, Sigma-Aldrich, Steinheim, Germany)
forimmunocytochemicalcharacterizationorplatedonto96-
well plates for cell viability assay. The viability of Schwann
cells was measured before and after incubation for 1hr, 2hrs,
and 3hrs in selected media (see below) at 4◦C, 37◦C, and
18◦C( Figure 1).
2.2. Characterization and Quantiﬁcation of Schwann Cells by
Immune Fluorescence. The purity of the prepared Schwann
cells was determined by indirect immunoﬂuorescence stain-
ing for Schwann cell characteristic marker anti-S100 (poly-
clonal Rabbit, Dako, Glostrup, Denmark) and visualized
with secondary antibody Alexa Fluor 546 (secondary anti-
body, donkey anti-rabbit, Invitrogen, Karlsruhe, Germany).
Nuclei were counterstained with DAPI (Vector Laboratories,
CA, USA). Quantiﬁcation of purity was obtained by count-
ing immunopositive S100 cells in ratio to the number of
nuclei. Schwann cell purity was >95% (data not shown).
2.3. Measurement of Metabolic Activity. Viability of Schwann
cells of sciatic nerves after incubation in selected media was
measured by the CellTiter-Blue (CTB) Cell Viability Assay
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Figure 1: Conditions for testing the metabolic activity of Schwann
cells in vitro after incubation in selected media including saline,
DMEM with 10% FCS, HBRM, and Leibovitz’s medium. Sciatic
nerves were incubated in these selected media at 4◦C, a room
temperature 18◦Ca n d3 7 ◦C. For each temperature condition,
Schwann cell metabolism was determined after 1hrs, 2hrs, and
3hrs.
(Promega, Madison, WI, USA), the CellTiter 96 AQueous
Nonradioactive Cell Proliferation Assay (Promega, Madison,
WI, USA), which indicates cell viability on the basis of cell
metabolism. The CTB assay uses the capacity of viable
cells reducing the dye resazurin to resoruﬁn, which emits
ﬂuorescence at 590nm. The intensity of ﬂuorescence is
proportional to the number of viable cells. As second in-
dependent test to verify results, the CellTiter 96 Aqueous
Assay contains a tetrazolium compound (MTS; [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt]) and PMS (phe-
nazine methosulfate) as an electron coupling reagent. Viable
cells reduce the MTS reagent into formazan. The absorbance
of formazan can be measured at 490nm and the quantity of
absorbance is directly proportional to the number of viable
cells.
Selectedmediaforstoragewere(1)isotonicsodiumchlo-
ride (NaCl 0.9%, Deltaselect GmbH, Dreieich), (2) DMEM
low glucose (1g/L) supplemented with L-Glutamine (PAA,
Pasching, Austria) and 10% FCS (fetal calf serum, Biochrom
AG, Berlin, Germany) and 1% Penicillin/Streptomycin (Bi-
ochrom AG, Berlin, Germany), (3) Hannover bioreactor
medium (HBRM; consisting out of 1000mL DMEM-F12
(Biochrom AG Berlin, Germany), 10mL/insulin-transferrinInternational Journal of Otolaryngology 3
selenium-A supplement (Gibco), 456IU Prednisolone,
400IU Insulin 108mg/mL Glucagon, 10µLS o l u d e c o r t i n
(10mg/mL), 5mL Amphomoronal (Biochrom AG, Berlin,
Germany), 20mL HEPES (Biochrom AG, Berlin, Germa-
ny), 50mg Hyaluronic acid (Sigma Aldrich, Germany),
5mg/L Penicillin/Streptomycin (Biochrom AG, Berlin, Ger-
many) and (4) Leibovitz’s medium (L-15 medium with
L-Glutamine mit 25mM Hepes, PAA, Pasching, Austria).
After incubation, Schwann cells were seeded onto 96-well
plates (Nunc, NY, USA) with 5000 Schwann cells/well. After
1hr ,2hrs,and3hrs,20µL of the CTB-reagent was added
to the dissociated cells and measurements were performed
after incubation according to the suppliers’ speciﬁcations.
All measurements were repeated at three independent times.
The background ﬂuorescence or absorbance of microtiter
plates with tested medium and lacking cells was subtracted
from these data.
2.4. Statistics. All statistical analysis of data was performed
using SigmaStat software (SPSS, Chicago, IL, USA). All data
were evaluated using one-way ANOVA and post hoc analysis
using the Student-Newman-Keuls method. All data are ex-
pressed as means ± SE.
3. Results
Standardized 2cm segments of rat sciatic nerve were
removed and Schwann cells were prepared for culture.
Schwann cell viability was determined after incubation in
either saline, DMEM, HBRM, or Leibovitz’s solution (n = 3
per group) for 0hr, 1hrs, 2hrs, and 3hrs. For each medium
condition and time point, metabolic activity was studied at
three separate temperatures: 4◦C, room temperature 18◦C,
and 37◦C( Figure 1). Cell viability was determined by two
independent methods: the CTB and MTS test.
3.1. Metabolic Activity of Schwann Cells at 4◦C. Metabolic
activity was studied upon dissociation of the Schwann cells
of rat sciatic nerves after incubation in the selected four
media conditions and measured by CTB (Figure 2 for line
chart and Figure 3 for bar chart). Schwann cell metabolic
activity incubated at 4◦C( Figure 2(a) and Figure 3(a),r e s p . )
was decreased at 1hr and remained decreased in the 2hrs
and 3hrs groups. In general, at 4◦C the metabolic activity
was the lowest for the DMEM condition. Thus, Schwann
cell metabolic activity in culture was reduced with time
with all three media signiﬁcantly. The cell viability was
more than reduced to half within the ﬁrst hour in all four
experimental groups. The greatest Schwann cell viability
in this set of experiments at 4◦C could be observed in
saline where cell metabolic activity was signiﬁcantly higher
than in DMEM and HBRM. The lowest viability was
obtained at 4◦C in DMEM with about 70% reduction
in metabolic activity within the ﬁrst hour followed by a
reduction, nearly complete loss of metabolic activity, of
99.7% to 0.3% after 3 hours. Cell viability was examined by
MTS.
3.2.Metabolic Activity ofSchwannCells atRoom Temperature.
At room temperature (Figure 2(b) and Figure 3(b),r e s p . ) ,
metabolic activity of cultured Schwann cells determined
by CTB decreased for the DMEM and HBRM conditions,
nominally was unchanged for the Leibovitz’s medium and
marginally increased in saline over time (Figures 2(b) and
3(b)). The reduction in metabolic activity was observed in
DMEM with most loss of cell viability within the ﬁrst hour
of more than 90%. An increase of cell metabolic activity
(132%) with incubation in saline occurred within the ﬁrst
2 hours of cell activity followed by a continued reduction
of approximately 10% within the third hour. The poorest
conditions were obtained at room temperature with DMEM.
Thus, the best Schwann cell activity at room temperature
could be seen in the saline group over the three-hour period
with increase of cell metabolism.
3.3. Metabolic Activity for Schwann Cells Incubated at 37◦C.
Metabolic activity for Schwann cells incubated at 37◦Ca n d
measured by CTB increased for those incubated in HBRM,
Leibovitz and saline (Figure 2(c) and Figure 3(c),r e s p e c -
tively). Activity of Schwann cells in HBRM increased nearly
4-fold within the ﬁrst hour followed by a slight reduction at
the 2-hour time point, but still showing an increase in cell
metabolism of 318% at the 3-hour time point. Incubation
in Leibovitz’s medium showed a similar 4-fold increase of
Schwann cell metabolism within the ﬁrst hour followed by
continued decrease within the next 2 hours of observation
period. After the three-hour period, there is still an increase
of activity of 100% noticeable. Schwann cells metabolism
after incubation in saline showed a 3-fold increase within the
ﬁrst hour resulting in an increase of activity of 120% after
3 hours. Schwann metabolism preincubated in DMEM did
not show an increase in metabolic activity. The increase in
metabolic activity for these HBRM, saline, and Leibovitz’s
medium peaked at 1hr after nerve incubation at 37◦C.
Metabolic activity was reduced for all three conditions at
2hrs and 3hrs, but remained higher than at 0hr. For nerves,
the metabolic activity remained continuously high when
incubated with HBRM at 2 and 3hrs, indicating a broader
time window for postincubation Schwann cell metabolic
activity than the other 3 media.
3.4. Metabolic Activity of Schwann Cells Measured by MTS at
4◦C, Room Temperature, and 37◦C. Additionally, Schwann
cell metabolism was also assessed as absorbance meas-
ured with MTS at 4◦C( Figure 4(a)), room temperature
(Figure 4(b)), and at 37◦C( Figure 4(c)) incubated in the
described media. At 4◦C, all conditions resulted after 3 hours
in massive reduction of cell viability. At room temperature,
incubation in HRBM and DMEM showed slightly better
results than NaCl and Leibovitz. Optimal cell viability with
increase of Schwann cell metabolism can be seen after
incubation in HBRM at 37◦Ca so b s e r v e db yd e t e r m i n a t i o n
of cell viability by reducing resazurin to resofurin with CTB
in Figure 2.
Thus, Schwann cell metabolic activity over time in cul-
ture from ex vivo nerves incubated in one of four media was
generally reduced at 4◦C and room temperature incubation4 International Journal of Otolaryngology
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Figure 2: This Figure and respectively, Figure 3: Schwann cell metabolism indicated as ﬂuorescence activity at 4◦C( a ) ,r o o mt e m p e r a t u r e
(b), and at 37◦C (in (c)) incubated in the described media. Cell viability was measured by reduction of resazurin to resofurin by CellTiter-
Blue(CTB)CellViabilityAssay.Mostreducedcellviabilitywasobservedafter3-hourincubationofSchwanncellsinDMEMat4◦C.Optimal
cell viability with increase of Schwann cell metabolism can be seen after incubation in HBRM at 37◦C. P<0.05.
temperatures over a time window for three hours as mea-
sured by CTB and MTS independently. Most reduction in
cell viability was observed within the ﬁrst hour of incubation
in both tests of more than 50% in all media at 4◦C. For
incubation at 37◦C, Schwann cell metabolic activity was
increased for nerve segments incubated in HBRM, Leibovitz,
and saline over the observation period of three hours. But,
there was no increase at 37◦C in Schwann cell metabolic
activity incubated in DMEM. While Schwann cell metabolic
activity peaked at the 1hr nerve incubation time point and
declinedforLeibovitz’sandsaline,theactivityremainedhigh
even at the 2- and 3-hour time points. Most reduced cell
viability was observed after 3-hour incubation of Schwann
cells in DMEM at 4◦C. Optimal cell viability with increase
of Schwann cell metabolism can be seen after incubation in
HBRMat37◦C.Thiscouldbeveriﬁedbytheresultsobtained
with the MTS at 37◦C.
4. Discussion
In this study, we demonstrated that Schwann cell metabolic
activity is dependent on several factors including temper-
ature, holding media, incubation, and holding time. The
greatest increase in metabolic activity of all these groups
was observed at 37◦C over a period of three hours. Here, a
signiﬁcantincreaseinmetabolicactivitycouldbeobservedinInternational Journal of Otolaryngology 5
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Figure 3
Leibovitz’s medium and HBRM with a 3-fold increase after
incubation of 3 hours in HBRM. Saline resulted in moderate
increase of 120% in comparison to the other groups at
37◦C.
Observing just 1 hour of incubation period at 37◦C, best
results were observed in correspondence to 3 three hours
in saline, Leibovitz’s medium, and HBRM with maximum
activitywitha4-foldincreaseafter1hourinbothconditions.
Most decrease in cell metabolic activity was observed at
nerves incubated at 4◦Ci na l l4e x p e r i m e n t a lg r o u p s .C e l l
metabolism was reduced to half after 3 hours in the saline
group and was close to zero metabolic activity in the DMEM
group. The DMEM group resulted in all three temperature
conditions in most reduction in cell metabolism activity. It
is important to point out that our data demonstrated that
incubation in the commonly used, the culture medium of
SchwannconsistingofDMEMwith10%serumdidnotresult
atanytimepoint,andtemperatureinanincrease,butinstead
inasigniﬁcantdecreaseincellmetabolismactivitywithinthe
three hour observation period. Thus, DMEM is suboptimal
as a medium for preservation of Schwann cell metabolism
and alternatives should be considered.6 International Journal of Otolaryngology
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Figure 4:SchwanncellmetabolismindicatedasabsorbancemeasuredwithMTSat4◦C(a),roomtemperature(b),andat37◦C(c)incubated
in the described media. At 4◦C all conditions resulted after 3 hours in massive reduction of cell viability. At room temperature incubation in
HRBM and DMEM showed slightly better results than NaCl and Leibovitz’s. Optimal cell viability with increase of Schwann cell metabolism
can be seen after incubation in HBRM at 37◦C as observed by independent determination of cell viability by CTB in Figure 2. P<0.05.
Schwann cells play an important role in peripheral
nerve regeneration; and poor survival of Schwann cells is
thought to inﬂuence the outcome of nerve transplantation
[15]. Reduced number of Schwann cells after suboptimal
storage conditions of donor nerve removed for autologous
cell transplantation, for example, in traumatic nerve defect
injuries or after wide tumor resection, could lead to a
reduction in growth factor production, less axonal guidance
of elongating axons resulting in increased sprouting, and
failure to connect to peripheral targets or even painful
neuroma formation [11].
For improvement of peripheral nerve regeneration, it
was shown that additional transplantation of Schwann cells
leads to more directed growth of regenerating axons and
a signiﬁcant better functional result with a greater nerve
conductionvelocityaftercrushlesionandaftermicrosurgical
repair [8–10]. The survival of Schwann cells could be
experimentally improved by overexpression of polysialic
acid [15] or addition of FK506 [16, 17]. Moreover, pre-
degeneration of nerve grafts resulted in improvement of
nerve regeneration based on the activation of Schwann cells
[17–20]. The eﬃcacy of 2–7 days of 14-day pre-degeneration
in DMEM of rat Schwann cell culture was described in a
recent study by Kraus et al. (2010) [21].
Moreover, further experimental studies demonstrated
the importance of seeded Schwann cells to improve the
eﬃcacy of acellular nerve grafts [22] or artiﬁcial nerve
guidance channels [23, 24]t oi m p r o v ee ﬀectiveness of nerveInternational Journal of Otolaryngology 7
repair.AdditionofSchwanncellstomuscleasnerveguidance
in peripheral nerve defect injuries resulted in signiﬁcant
better functional and histological results than without cell
supplement indicating the important role of Schwann cells
for enhancement of axonal regeneration and remyelination
after injury. Schwann cell-seeded bioartiﬁcial nerve conduits
are subjects of several ongoing studies to improve functional
results after nerve repair and to bridge extended nerve
defects [24, 25]. Thus, incubation for optimal Schwann
cell metabolic activity of donor nerve or of Schwann cell
suspension for direct transplantation is essential and under-
lines the importance of our presented data. To verify our
observed results, we performed independent test methods
including using the CTB and MTS assay for comparison of
cell metabolism according to previous reports [26, 27]. We
archived similar results with all test methods demonstrating
optimal cell viability of Schwann cell metabolism after 3-
hour incubation in HBRM at 37◦C.
In contrast to previous reports, we directly investigated
Schwann cell viability which has a critical inﬂuence on the
histological and functional results after nerve repair and
nerve transplants after dissociation in a short period of time
of three hours which is clinical relevant. Previous reports
examined Schwann cell proliferation after 2 days and 3 days
of culture [28]. Here, progressive increase of proliferation
over 3 days could be observed. Successful storage of periph-
eral nerve before transplantation after this time could be
demonstrated in an experimental study in rats by using
polyphenol to reduce oxidative stress [29]. In this study,
nerve segments were kept for up to 30 days in polyphe-
nol solution followed by determination of nerve viability
by calcein-AM/ethidium homodimer staining. In another
study, storage in polyphenol solution was compared to
conventional University of Wisconsin solution for long-term
peripheral nerve banking [30].
5. Conclusion
The results demonstrated the enhancement of Schwann cell
metabolism and optimal Schwann cell viability after incu-
bation at 37◦C with usage of either Leibovitz or HBRM
up to three hours. The commonly used saline solution at
room temperature demonstrated a slight increase in cell me-
tabolism at 37◦C. To obtain optimal results after nerve trans-
plantation, removed nerves should be stored in the described
conditions with usage of Leibovitz’s medium or HBRM in
37◦C upon transplantation. Additional experimental studies
will determine if the presented results in vitro could be
conﬁrmed in vivo. With regard to clinical application, in-
creased SC viability in autologous nerve transplants could
result in enhanced axonal regeneration and remyelination
leading to improved functional outcome after nerve grafting.
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SC: Schwann cell
HBRM: Hannover bioreactor medium
CTB: Cell Titer-Blue Cell Viability Assay
DAPI: 4 , 6-diamidino-2-phenylindol
DMEM: Dulbecco’s modiﬁed Eagles’medium
EDTA: Ethylenediamine tetraacetic acid
FCS: Fetal calf serum
HEPES: 2-(4-(2-Hydroxyethyl)-1-piperazinyl)-
ethansulfons¨ aure
MTS: Tetrazolium salt
([3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner
salt])
NaCl 0.9%: Isotonic 0.9% sodium chloride
NGF: Nerve growth factor
PBS: Phosphate buﬀered saline solution
PMS: Phenazine methosulfate
p75NGFR: Low aﬃnity nerve growth factor
receptor
RT: Room temperature (18◦C).
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